My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 115

    1.

    A new paradigm for the treatment of sepsis: is it time to consider combination therapy?

    Cross AS, Opal SM.

    Ann Intern Med. 2003 Mar 18;138(6):502-5. Review.PMID: 12639085 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    A blueprint for a sepsis protocol.

    Shapiro NI, Howell M, Talmor D.

    Acad Emerg Med. 2005 Apr;12(4):352-9.PMID: 15805328 [PubMed - indexed for MEDLINE]Related articles

    3.

    Advances in sepsis therapy.

    Glück T, Opal SM.

    Drugs. 2004;64(8):837-59. Review.PMID: 15059039 [PubMed - indexed for MEDLINE]Related articles

    4.

    The use of activated protein C (drotrecogin alfa (activated)) in the treatment of severe sepsis.

    Murgo M, Adamson H, Boyle M.

    Aust Crit Care. 2003 Nov;16(4):133-43. Review.PMID: 14692158 [PubMed - indexed for MEDLINE]Related articles

    5.

    New additions to the intensive care armamentarium.

    Rice TW, Bernard GR.

    Drugs Today (Barc). 2004 Feb;40(2):157-70. Review.PMID: 15045037 [PubMed - indexed for MEDLINE]Related articles

    6.

    Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008.

    Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL.

    Intensive Care Med. 2008 Jan;34(1):17-60. Epub 2007 Dec 4. Erratum in: Intensive Care Med. 2008 Apr;34(4):783-5. PMID: 18058085 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Optimum treatment of severe sepsis and septic shock: evidence in support of the recommendations.

    Balk RA.

    Dis Mon. 2004 Apr;50(4):168-213. Review.PMID: 15133467 [PubMed - indexed for MEDLINE]Related articles

    8.

    Role of activated protein C in the pathophysiology of severe sepsis.

    Dettenmeier P, Swindell B, Stroud M, Arkins N, Howard A.

    Am J Crit Care. 2003 Nov;12(6):518-24; quiz 525-6. Review.PMID: 14619357 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    System interactions.

    Singer M.

    Novartis Found Symp. 2007;280:252-62; discussion 262-5. Review.PMID: 17380799 [PubMed - indexed for MEDLINE]Related articles

    10.

    [Understanding the pathogenetic mechanisms of SIRS and sepsis and development of innovative therapies of sepsis]

    Aikawa N, Fujishima S.

    Nippon Rinsho. 2004 Dec;62(12):2173-6. Japanese. PMID: 15597781 [PubMed - indexed for MEDLINE]Related articles

    11.

    [Development of antituberculous drugs: current status and future prospects]

    Tomioka H, Namba K.

    Kekkaku. 2006 Dec;81(12):753-74. Review. Japanese. PMID: 17240921 [PubMed - indexed for MEDLINE]Related articles

    12.

    Overview of resistance to systemic therapy in patients with breast cancer.

    Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN.

    Adv Exp Med Biol. 2007;608:1-22. Review.PMID: 17993229 [PubMed - indexed for MEDLINE]Related articles

    13.

    Drug intervention trials in sepsis: divergent results.

    Polderman KH, Girbes AR.

    Lancet. 2004 May 22;363(9422):1721-3. Review.PMID: 15158636 [PubMed - indexed for MEDLINE]Related articles

    14.

    Emerging therapies for sepsis and septic shock.

    Oh HM.

    Ann Acad Med Singapore. 1998 Sep;27(5):738-43. Review.PMID: 9919353 [PubMed - indexed for MEDLINE]Related articles

    15.

    The systemic inflammatory response syndrome.

    Weigand MA, Hörner C, Bardenheuer HJ, Bouchon A.

    Best Pract Res Clin Anaesthesiol. 2004 Sep;18(3):455-75. Review.PMID: 15212339 [PubMed - indexed for MEDLINE]Related articles

    16.

    Treatment of severe sepsis: where next? Current and future treatment approaches after the introduction of drotrecogin alfa.

    Rice TW.

    Vasc Health Risk Manag. 2006;2(1):3-18. Review.PMID: 17319465 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    [Frontier of mycobacterium research--host vs. mycobacterium]

    Okada M, Shirakawa T.

    Kekkaku. 2005 Sep;80(9):613-29. Japanese. PMID: 16245793 [PubMed - indexed for MEDLINE]Related articles

    18.

    Benefit-risk assessment of drotrecogin alfa (activated) in the treatment of sepsis.

    De Backer D.

    Drug Saf. 2007;30(11):995-1010. Review.PMID: 17973539 [PubMed - indexed for MEDLINE]Related articles

    19.

    Antibiotic selection for patients with septic shock.

    Simon D, Trenholme G.

    Crit Care Clin. 2000 Apr;16(2):215-31. Review.PMID: 10768080 [PubMed - indexed for MEDLINE]Related articles

    20.

    Effect of factor V Leiden polymorphism in severe sepsis and on treatment with recombinant human activated protein C.

    Yan SB, Nelson DR.

    Crit Care Med. 2004 May;32(5 Suppl):S239-46.PMID: 15118525 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity